C12Y 112/01
Oxidoreductases acting on hydrogen as donor: with nad+ or nadp+ as acceptor
Official title: with NAD+ or NADP+ as acceptor (1.12.1)
C12Y112/01 (Oxidoreductases acting on hydrogen as donor: with nad+ or nadp+ as acceptor) appears on 8 US grants and 9 published applications in this corpus.
Search patents in C12Y- Granted patents
- 8
- Published applications
- 9
- Assignees
- 11
- Inventors
- 22
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 2 |
| 2019 | 0 | 0 |
| 2020 | 3 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 2 | 0 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- NAD(P) depot for NAD(P)-dependent enzyme-based sensors9 Jun 2026US 12,649,944 B2Abbott Diabetes Care Inc.
- Genetically modified phototrophic cell for in-vivo production of hydrogen9 Dec 2025US 12,492,413 B2University of Kassel
- NAD(P) depot for NAD(P)-dependent enzyme-based sensors2 Sep 2025US 12,404,535 B2Abbott Diabetes Care Inc.
- Clostridium acetobutylicum strains unable to produce hydrogen and useful for the continuous production of chemicals and fuels2 Jun 2020US 10,669,530 B2Centre National De La Recherche Scientifique
- Method for producing mercaptans by hydrogen-assisted disulfide enzyme hydrogenolysis12 May 2020US 10,648,007 B2Arkema France
- Nad(p) depot for nad(p)-dependent enzyme-based sensors17 Sep 2026US 2026/0275399 A1Abbott Diabetes Care Inc.
- Host cell with increased cellular reducing power from a heterologous hydrogenase25 Jun 2026US 2026/0176639 A1The Regents of the University of California
- Nad(p) depot for nad(p)-dependent enzyme-based sensors22 Aug 2024US 2024/0279708 A1Abbott Diabetes Care Inc.
- Genetically modified phototrophic cell for in-vivo production of hydrogen5 Jan 2023US 2023/0002791 A1University of Kassel
- Nad(p) depot for nad(p)-dependent enzyme-based sensors16 Jun 2022US 2022/0186277 A1Abbott Diabetes Care Inc.
Most cited
By later US patents